Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.
about
Use of Cell-Penetrating Peptides in Dendritic Cell-Based VaccinationProphylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directionsAtezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.Trial watch: Dendritic cell-based interventions for cancer therapy.
P2860
Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Allogeneic partially HLA-match ...... : a clinical phase I/II study.
@en
Allogeneic partially HLA-match ...... : a clinical phase I/II study.
@nl
type
label
Allogeneic partially HLA-match ...... : a clinical phase I/II study.
@en
Allogeneic partially HLA-match ...... : a clinical phase I/II study.
@nl
prefLabel
Allogeneic partially HLA-match ...... : a clinical phase I/II study.
@en
Allogeneic partially HLA-match ...... : a clinical phase I/II study.
@nl
P2093
P2860
P50
P356
P1476
Allogeneic partially HLA-match ...... : a clinical phase I/II study.
@en
P2093
Anna Takvorian
Anne Flörcken
Antje van Lessen
Antonio Pezzutto
Bernd Dörken
Constanze Schönemann
Joachim Kopp
Jörg Westermann
Kamran Movassaghi
P2860
P304
P356
10.4161/HV.24149
P577
2013-03-04T00:00:00Z